100 percent recovery rate for COVID-19 patients treated with Zofin™

Good News Notes: “Organicell Regenerative Medicine  has announced that all ten hospitalised COVID-19 patients treated with Zofin™ have recovered and been discharged from hospital. These patients are the first to be treated with the acellular biologic therapeutic derived from perinatal sources in a Phase I/II randomised, double-blinded, placebo-controlled trial. The study is evaluating the safety…